Publications by authors named "Tanis Godwin"

Claim this Profile
H
Hereditary diffuse gastric cancer: the evolution of a cancer syndrome.
Lyvianne Decourtye-Espiard, Tanis Godwin, Parry Guilford

J R Soc N Z· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.
Nicola Bougen-Zhukov, Lyvianne Decourtye-Espiard, Wilson Mitchell, Kieran Redpath, Jacqui Perkinson, Tanis Godwin

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking.
Tom Brew, Nicola Bougen-Zhukov, Wilson Mitchell, Lyvianne Decourtye, Emily Schulpen, Tanis Godwin

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors.
Lyvianne Decourtye-Espiard, Nicola Bougen-Zhukov, Tanis Godwin, Tom Brew, Emily Schulpen

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing.
Katherine Dixon, Tom Brew, David Farnell, Tanis D Godwin, Simon Cheung

J Pathol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary diffuse gastric cancer: updated clinical practice guidelines.
Vanessa R Blair, Maybelle McLeod, Fátima Carneiro, Daniel G Coit, Johanna L D'Addario, Tanis D Godwin

Lancet Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells.
Nicola Bougen-Zhukov, Yasmin Nouri, Tanis Godwin, Megan Taylor, Christopher Hakkaart

Cancers (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.
Tanis D Godwin, S Thomas Kelly, Tom P Brew, Nicola M Bougen-Zhukov, Andrew B Single

Gastric Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer.
Joana Figueiredo, Soraia Melo, Kimberley Gamet, Tanis Godwin, Susana Seixas

Mol Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin-Deficient Cells.
Bryony J Telford, Augustine Chen, Henry Beetham, James Frick, Tom P Brew, Tanis Godwin

Mol Cancer Ther· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.
Augustine Chen, Henry Beetham, Michael A Black, Rashmi Priya, Bryony J Telford, Tanis D Godwin

BMC Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis